Coagulation factor I
About the parameter
The fibrinogen test is intended for the quantitative determination of the protein concentration. High levels are generally associated with cardiovascular diseases.
The parameter may be elevated due to any form of inflammation, as Fibrinogen is an acute-phase protein (similar to CRP). Low levels, on the other hand, can indicate a systemic activation of the clotting system – consumption of clotting factors is then faster than synthesis.
The fibrinogen antibody interacts with the fibrinogen in the plasma forming immune complexes. The immune complexes cause an increase in light scattering, which correlates with the concentration of plasma fibrinogen.
Citrated- or lithium-heparine plasma is required for this assay.
Immediately after collection, centrifuge samples and remove plasma from cells.
This is an immunoturbidimetric assay measured at 340 nm.
0 – 8 g/l (0 – 800 mg/dl) (LOT dependent)
The Test takes approx. 8 minutes to finish.
More details can be found in the package insert.
Please note: All package inserts provided on this website are intended for information purposes only! Always process all tests, controls and calibrators strictly according to the package insert provided with the kit.
Find the evaluation study for the Eurolyser fibrinogen assay here: Eurolyser fibrinogen test evaluation
VT 0120 Fibrinogen test kit (containing 16 tests)
VT 0121 Fibrinogen test kit (containing 6 tests)
VT 1200 Fibrinogen control kit (decision level)
18. August 2020
SDMA: A new veterinary assay for evaluation of chronic kidney diseases...» Read more...
17. August 2020
Phenobarbital: A next generation epilepsy monitoring assay...» Read more...
10. December 2019
Launch of bidirectional connectivity: a feature for CUBE series instruments...» Read more...
5. December 2019